Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanfilipo, M. P.
Right arrow Articles by Bakshi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanfilipo, M. P.
Right arrow Articles by Bakshi, R.
NEUROLOGY 2006;66:685-692
© 2006 American Academy of Neurology

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis

Michael P. Sanfilipo, MD, Ralph H.B. Benedict, PhD, Bianca Weinstock-Guttman, MD and Rohit Bakshi, MD, FAAN

From the Departments of Neurology (M.P.S., R.H.B.B., B.W.-G.) and Psychiatry (R.H.B.B.), SUNY-University at Buffalo School of Medicine and Biomedical Sciences; Buffalo Neuroimaging Analysis Center (M.P.S., R.H.B.B.); The Jacobs Neurological Institute (B.W.-G., R.H.B.B.), Buffalo, NY; and Center for Neurological Imaging (R.B.), Partners MS Center, Departments of Neurology and Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.

Address correspondence and reprint requests to Dr. Rohit Bakshi, Brigham & Women’s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur–HIM 730, Boston, MA 02115; e-mail: rbakshi{at}bwh.harvard.edu

Background: The relationship of gray and white matter atrophy in multiple sclerosis (MS) to neuropsychological and neuropsychiatric impairment has not been examined.

Methods: In 40 patients with MS and 15 age-/sex-matched normal controls, the authors used SPM99 to obtain whole brain normalized volumes of gray and white matter, as well as measured conventional lesion burden (total T1 hypointense and FLAIR hyperintense lesion volume). The whole brain segmentation was corrected for misclassification related to MS brain lesions. To compare the effects of gray matter, white matter, and lesion volumes with respect to brain-behavior relationships, the MS group (disease duration = 11.2 ± 8.8 years; EDSS score = 3.3 ± 1.9) underwent neuropsychological assessment, and was compared to a separate, larger group of age-/sex-matched normal controls (n = 83).

Results: The MS group had smaller gray (p = 0.009) and white matter volume (p = 0.018), impaired cognitive performance (verbal memory, visual memory, processing speed, and working memory) (all p < 0.0001), and greater neuropsychiatric symptoms (depression, p < 0.0001; dysphoria, p < 0.0001; irritability, p < 0.0001; anxiety, p < 0.0001; euphoria, p = 0.006; agitation, p = 0.02; apathy, p = 0.02; and disinhibition, p = 0.11) vs controls. Hierarchical stepwise regression analysis revealed that whole gray and white matter volumes accounted for greater variance than lesion burden in explaining cognitive performance and neuropsychiatric symptoms. White matter volume was the best predictor of mental processing speed and working memory, whereas gray matter volume predicted verbal memory, euphoria, and disinhibition.

Conclusion: Both gray and white brain matter atrophy contribute to neuropsychological deficits in multiple sclerosis.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the March 14 issue to find the title link for this article.

Supported in part by an Alpha Omega Alpha Student Research Fellowship (M. Sanfilipo), a University at Buffalo School of Medicine and Biologic Sciences Summer Research Fellowship (M. Sanfilipo), and by research grants from the NIH (NIH-National Institute of Neurologic Disorders and Stroke 1 K23 NS42379-01, R. Bakshi), National Multiple Sclerosis Society (RG 3258A2/1, BWG, R. Bakshi; RG 3574A1, R. Bakshi), and National Science Foundation (DBI-0234895, BWG, R. Bakshi).

Disclosure: The authors report no conflicts of interest.

Received May 3, 2005. Accepted in final form November 10, 2005.




This article has been cited by other articles:


Home page
Therapeutic Advances in Neurological DisordersHome page
I. S. Haussleiter, M. Brune, and G. Juckel
Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment
Therapeutic Advances in Neurological Disorders, January 1, 2009; 2(1): 13 - 29.
[Abstract] [PDF]


Home page
NeurologyHome page
B. A. Cohen
Identification, causation, alleviation, and prevention of complications (ICAP): An approach to symptom and disability management in multiple sclerosis
Neurology, December 9, 2008; 71(24_suppl_3): S14 - S20.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J Furby, T Hayton, V Anderson, D Altmann, R Brenner, J Chataway, R. Hughes, K. Smith, D. Miller, and R Kapoor
Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis
Multiple Sclerosis, September 1, 2008; 14(8): 1068 - 1075.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Summers, J Swanton, K Fernando, C Dalton, D H Miller, L Cipolotti, and M A Ron
Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 955 - 958.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M. Summers, L. Fisniku, V. Anderson, D. Miller, L. Cipolotti, and M. Ron
Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier
Multiple Sclerosis, March 1, 2008; 14(2): 197 - 204.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
J. M. RODRIGUEZ-SANCHEZ, B. CRESPO-FACORRO, C. GONZALEZ-BLANCH, R. PEREZ-IGLESIAS, J. L. VAZQUEZ-BARQUERO, and the PAFIP Group Study
Cognitive dysfunction in first-episode psychosis: the processing speed hypothesis
The British Journal of Psychiatry, December 1, 2007; 191(51): s107 - s110.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. K. Houtchens, R.H.B. Benedict, R. Killiany, J. Sharma, Z. Jaisani, B. Singh, B. Weinstock-Guttman, C. R.G. Guttmann, and R. Bakshi
Thalamic atrophy and cognition in multiple sclerosis
Neurology, September 18, 2007; 69(12): 1213 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. P. Amato, E. Portaccio, B. Goretti, V. Zipoli, M. Battaglini, M. L. Bartolozzi, M. L. Stromillo, L. Guidi, G. Siracusa, S. Sorbi, et al.
Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis
Arch Neurol, August 1, 2007; 64(8): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. Pirko, C. F. Lucchinetti, S. Sriram, and R. Bakshi
Gray matter involvement in multiple sclerosis
Neurology, February 27, 2007; 68(9): 634 - 642.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.